Payment overview · 2025
General Payments
$80.53
5 reported records · 4 companies
Healthcare provider profile · identity verified
John Edward Vanmetre, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · VICTORIA, TX · NPI 1669474284
Verified facts
What the public records show
CMS Open Payments records show John Edward Vanmetre, M.D. received $80.53 in general payments during 2025 across 5 reported records.
Bayer Healthcare Pharmaceuticals Inc. accounted for 38.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $31.22 | 38.8% | 2 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $18.93 | 23.5% | 1 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$15.21 | 18.9% | 1 | 2025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $15.17 | 18.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $80.53 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $31.22 | 2 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $18.93 | 1 | 2025 |
Source payment records
|
|||||
| INCEPTIV Normalized: inceptiv |
Device | Medtronic, Inc. | $15.21 | 1 | 2025 |
Source payment records
|
|||||
| XIFAXAN Normalized: xifaxan |
Drug | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.17 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 617 | 189 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 439 | 86 |
| Gabapentin | Gabapentin | 426 | 122 |
| Levothyroxine Sodium | Levothyroxine Sodium | 412 | 110 |
| Amlodipine Besylate | Amlodipine Besylate | 407 | 128 |
| Furosemide | Furosemide | 397 | 119 |
| Lisinopril | Lisinopril | 392 | 124 |
| Potassium Chloride | Potassium Chloride | 309 | 91 |
| Eliquis | Apixaban | 295 | 56 |
| Metoprolol Tartrate | Metoprolol Tartrate | 294 | 91 |
| Losartan Potassium | Losartan Potassium | 280 | 81 |
| Metformin Hcl | Metformin Hcl | 266 | 72 |
| Tramadol Hcl | Tramadol Hcl | 258 | 81 |
| Sertraline Hcl | Sertraline Hcl | 243 | 53 |
| Metoprolol Succinate | Metoprolol Succinate | 240 | 71 |
| Alprazolam | Alprazolam | 223 | 52 |
| Donepezil Hcl | Donepezil Hcl | 223 | 58 |
| Trazodone Hcl | Trazodone Hcl | 211 | 45 |
| Tamsulosin Hcl | Tamsulosin Hcl | 189 | 64 |
| Pantoprazole Sodium | Pantoprazole Sodium | 188 | 87 |
| Clopidogrel | Clopidogrel Bisulfate | 163 | 48 |
| Omeprazole | Omeprazole | 156 | 50 |
| Escitalopram Oxalate | Escitalopram Oxalate | 154 | 37 |
| Levetiracetam | Levetiracetam | 138 | 25 |
| Memantine Hcl | Memantine Hcl | 133 | 30 |
| Hydrochlorothiazide | Hydrochlorothiazide | 127 | 40 |
| Duloxetine Hcl | Duloxetine Hcl | 124 | 26 |
| Montelukast Sodium | Montelukast Sodium | 122 | 36 |
| Carvedilol | Carvedilol | 115 | 36 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 111 | 42 |
| Famotidine | Famotidine | 111 | 42 |
| Pregabalin | Pregabalin | 110 | 22 |
| Pravastatin Sodium | Pravastatin Sodium | 109 | 41 |
| Spironolactone | Spironolactone | 106 | 29 |
| Divalproex Sodium | Divalproex Sodium | 101 | 25 |
| Hydralazine Hcl | Hydralazine Hcl | 101 | 33 |
| Mirtazapine | Mirtazapine | 99 | 27 |
| Clonazepam | Clonazepam | 94 | 20 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 93 | 21 |
| Fluoxetine Hcl | Fluoxetine Hcl | 88 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 84 | 31 |
| Myrbetriq | Mirabegron | 84 | 16 |
| Tizanidine Hcl | Tizanidine Hcl | 84 | 24 |
| Buspirone Hcl | Buspirone Hcl | 83 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 83 | 36 |
| Quetiapine Fumarate | Quetiapine Fumarate | 83 | 17 |
| Zolpidem Tartrate | Zolpidem Tartrate | 82 | 22 |
| Oxybutynin Chloride | Oxybutynin Chloride | 80 | 20 |
| Allopurinol | Allopurinol | 73 | 20 |
| Ozempic | Semaglutide | 71 | 18 |
| Entresto | Sacubitril/Valsartan | 67 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 66 | 23 |
| Simvastatin | Simvastatin | 66 | 25 |
| Xarelto | Rivaroxaban | 64 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 63 | 24 |
| Prednisone | Prednisone | 62 | 33 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 60 | 14 |
| Rivastigmine | Rivastigmine Tartrate | 58 | suppressed |
| Nifedipine Er | Nifedipine | 56 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 56 | suppressed |
| Baclofen | Baclofen | 55 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 53 | 25 |
| Glipizide | Glipizide | 52 | 17 |
| Hydrocortisone | Hydrocortisone | 52 | 15 |
| Olanzapine | Olanzapine | 52 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 49 | 15 |
| Cephalexin | Cephalexin | 47 | 20 |
| Ezetimibe | Ezetimibe | 46 | 15 |
| Januvia | Sitagliptin Phosphate | 46 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 45 | 38 |
| Naproxen | Naproxen | 45 | 18 |
| Alendronate Sodium | Alendronate Sodium | 43 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 43 | 23 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 43 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 43 | 14 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 43 | suppressed |
| Lactulose | Lactulose | 42 | 28 |
| Levofloxacin | Levofloxacin | 42 | 32 |
| Latanoprost | Latanoprost | 40 | suppressed |
| Topiramate | Topiramate | 40 | suppressed |
| Tradjenta | Linagliptin | 40 | suppressed |
| Colchicine | Colchicine | 39 | 13 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 39 | 28 |
| Brilinta | Ticagrelor | 37 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 37 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 36 | 13 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 36 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 35 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 34 | suppressed |
| Jardiance | Empagliflozin | 34 | 15 |
| Trulicity | Dulaglutide | 34 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 33 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 33 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 33 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 33 | 27 |
| Diazepam | Diazepam | 32 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 32 | suppressed |
| Sucralfate | Sucralfate | 32 | 11 |
| Aripiprazole | Aripiprazole | 31 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 31 | 11 |
| Glimepiride | Glimepiride | 31 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 31 | 15 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 30 | 27 |
| Fentanyl | Fentanyl | 30 | suppressed |
| Meloxicam | Meloxicam | 30 | 11 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 30 | 19 |
| Clonidine Hcl | Clonidine Hcl | 29 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 29 | 14 |
| Lorazepam | Lorazepam | 29 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 29 | suppressed |
| Celecoxib | Celecoxib | 28 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 27 | suppressed |
| Phenytoin | Phenytoin | 27 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 26 | 11 |
| Finasteride | Finasteride | 25 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 25 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 24 | 15 |
| Doxazosin Mesylate | Doxazosin Mesylate | 24 | suppressed |
| Lamotrigine | Lamotrigine | 24 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 24 | suppressed |
| Mounjaro | Tirzepatide | 24 | suppressed |
| Nitroglycerin | Nitroglycerin | 24 | 18 |
| Nystatin | Nystatin | 24 | 13 |
| Sodium Chloride | 0.9 % Sodium Chloride | 24 | suppressed |
| Ondansetron Odt | Ondansetron | 23 | 16 |
| Benztropine Mesylate | Benztropine Mesylate | 22 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 22 | suppressed |
| Constulose | Lactulose | 22 | 12 |
| Ibuprofen | Ibuprofen | 22 | 11 |
| Vancomycin Hcl | Vancomycin Hcl | 22 | 13 |
| Azithromycin | Azithromycin | 21 | 17 |
| Bupropion Xl | Bupropion Hcl | 21 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 21 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 21 | suppressed |
| Temazepam | Temazepam | 21 | suppressed |
| Fluconazole | Fluconazole | 20 | 14 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 20 | 12 |
| Meropenem | Meropenem | 20 | suppressed |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Risperidone | Risperidone | 20 | suppressed |
| Cefdinir | Cefdinir | 18 | 12 |
| Dicyclomine Hcl | Dicyclomine Hcl | 18 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Methocarbamol | Methocarbamol | 18 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 17 | 11 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 17 | 12 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 17 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 17 | suppressed |
| Rivastigmine | Rivastigmine | 17 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 17 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 16 | suppressed |
| Torsemide | Torsemide | 16 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 16 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 15 | 13 |
| Folic Acid | Folic Acid | 15 | suppressed |
| Linzess | Linaclotide | 15 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 15 | suppressed |
| Mupirocin | Mupirocin | 15 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 15 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 15 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 14 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 14 | suppressed |
| Phenobarbital | Phenobarbital | 14 | suppressed |
| Amoxicillin | Amoxicillin | 13 | suppressed |
| Atenolol | Atenolol | 13 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Enulose | Lactulose | 13 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 13 | suppressed |
| Vascepa | Icosapent Ethyl | 13 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 12 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Np Thyroid | Thyroid,pork | 12 | suppressed |
| Phenytek | Phenytoin Sodium Extended | 12 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 12 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 12 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Captopril | Captopril | 11 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 11 | suppressed |
| Dipyridamole | Dipyridamole | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 11 | suppressed |
| Ingrezza | Valbenazine Tosylate | 11 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Methotrexate | Methotrexate Sodium | 11 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 11 | suppressed |
| Ramelteon | Ramelteon | 11 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 11 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 11 | suppressed |
| Zonisamide | Zonisamide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $80.53 · 5 records | Bayer Healthcare Pharmaceuticals Inc. | INCEPTIV, Kerendia, REXULTI, XIFAXAN | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error